Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Author:

Llovet Josep M,Kudo Masatoshi,Merle Philippe,Meyer Tim,Qin Shukui,Ikeda Masafumi,Xu Ruocai,Edeline Julien,Ryoo Baek-Yeol,Ren Zhenggang,Masi Gianluca,Kwiatkowski Mariusz,Lim Ho Yeong,Kim Jee Hyun,Breder Valeriy,Kumada Hiromitsu,Cheng Ann-Lii,Galle Peter R,Kaneko Shuichi,Wang Anran,Mody Kalgi,Dutcus Corina,Dubrovsky Leonid,Siegel Abby B,Finn Richard S,Strasser Simone,Thompson Alexander,Roohullah Aflah,Sievert William,Andelkovic Vladimir,Knox Jennifer,Davies Janine,Asselah Jamil,Brahmania Mayur,Majeed Habeeb,Villanueva Luis,Yanez Weber Patricio,Garrido Marcelo,Pizarro Gonzalo Ignacio,Yanez Nicolas,Xu Ruocai,Ou Shuangyan,Ren Zhenggang,Pan Hongming,Meng Zhiqiang,Gu Kangsheng,Chen Xi,Zhang Tao,Hao Chunyi,Cao Peiguo,Guo Yabing,Qin Shukui,Xiao Juxiang,Fang Weijia,Wang Xin,Bai Yuxian,Chen Xiaoming,Yan Dong,Zhao Hong,Ying Jieer,Bonilla Carlos,Urrego Olga,Zambrano Angela,Lema Mauricio,Restrepo Gutierrez Juan Carlos,Cardona Andres,Franco Millan Sandra,Oscar Madiedo,Ramos Victor,Merle Philippe,LeSourd Samuel,Edeline Julien,Bronowicki Jean-Pierre,Bourliere Marc,Cattan Stephane,Bouattour Mohamed,Mineur Laurent,Regnault Helene,Dauvois Barbara,Schulze Kornelius,Folprecht Gunnar,Geier Andreas,Waidmann Oliver,Finkelmeier Fabian,Venerito Marino,Berres Marie-Luise,Berg Thomas,Lange Christian,Schmidt Hartmut,Waldschmidt Dirk T,Bitzer Michael,McDermott Ray,Duffy Austin,Masi Gianluca,Zagonel Vittorina,Tonini Giuseppe,Piscaglia Fabio,Gori Stefania,Rizzo Mimma,Biscaldi Elisa,Foltran Luisa,Cabibbo Giuseppe,Ikeda Masafumi,Kudo Masatoshi,Aikata Hiroshi,Numata Kazushi,Marusawa Hiroyuki,Kato Naoya,Kurosaki Masayuki,Morimoto Manabu,Yamashita Tatsuya,Koga Hironori,Masaki Tsutomu,Tateishi Ryosuke,Inaba Yoshitaka,Arakawa Tomohiro,Suzuki Yoshiyuki,Akua Norio,Kobayashi Masahiro,Hosaka Tetsuya,Nakamuta Makoto,Oza Noriko,Kondo Shunsuke,Furuse Junji,Nagashima Fumio,Kitano Masayuki,Takaguchi Koichi,Ryoo Baek-Yeol,Lim Ho Yeong,Kim Jee Hyun,Kim Tae-You,Kim Han Sang,Hernandez Hernandez Carlos,Motola Kuba Daniel,Segura Gonzalez Manuel,Cabrera Luviano Jesus,Huitzil Melendez Fidel,Ramirez Godinez Francisco,Silva-Bravo Fernando,Gane Edward,Stedman Catherine,Kwiatkowski Mariusz,Wyrwicz Lucjan,Nowakowska-Zajdel Ewa,Kraj Leszek,Janczewska Ewa,Surma-Wlodarczyk Renata,Breder Valeriy,Sekacheva Marina,Orlova Rashida,Vasilyev Alexander,Zukov Ruslan,Vladimirov Vladimir,Minguez Beatriz,Matilla Pena Ana,Fernandez Castroagudin Javier,Romero Gomez Manuel,Luis Lledo Jose,Rubin Angel,Garcia Sanchez Araceli,Calleja Panero Jose,Yu Ming-Chin,Shen Ying-Chun,Huang Yi-Hsiang,Jeng Long-Bin,Chang Ting-Tsung,Yang Sheng-Shun,Chen Shinn-Cherng,Dechaphunkul Arunee,Tanwandee Tawesak,Leerapun Apinya,Seker Mesut,Harputluoglu Hakan,Cicin Irfan,Oksuzoglu Berna,Bilici Mehmet,Sezgin Goksu Sema,Artac Mehmet,Cil Timucin,Yalcin Suayib,Meyer Tim,Sarker Debashis,Rao Ankit,Palmer Daniel,Evans Jeff,Hubner Richard,Finn Richard,Ulahannan Susanna,Zakari Ahmed,Feun Lynn,Al-Rajabi Raed,Sung Max,He Aiwu,Kardosh Adel,Goyal Lipika,Li Daneng,Goyal Lipika,Choi Minsig,Posada Juan,Dodlapati Jyothi,Shroff Rachna,Agrawal Saurabh,Gopaluni Srivalli,Akce Mehmet,Alese Olatunji,Baron Ari,Dunne Richard,Loaiza-Bonilla Arturo,Frenette Catherine

Publisher

Elsevier BV

Subject

Oncology

Cited by 82 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3